glp-1 drugs for addiction Weight-Loss Could Address a Range of Addictions Weight loss drugs and addiction:

& Terada, H

Ferraz M, Rho HS, Hemerich D, Henning HHW, van Tol HTA, Holker M, Besenfelder U, Mokry M, Vos P, Stout TAE, Le Gac S, Gadella BM (2018) An oviduct-on-a-chip provides an enhanced in vitro environment for zygote genome reprogramming

Improvement in Gastrointestinal Health: BPC-157, with its origins in gastric juice, has demonstrated significant potential in combating and possibly preventing gastrointestinal disorders, including inflammatory bowel disease, Crohns disease, and symptoms of leaky gut

Whether this should be regarded as specific metabolic treatment, targeting only the metabolic alterations of the syndrome, is debatable, since the improvement in metabolic conditions, e.g., insulin resistance, would tenably have a positive impact also in gonadal function in women with PCOS

A compelling observational study by Goderidze et al

Molkentin, J